NEW YORK (GenomeWeb) – NxGen MDx said today its genetic screening and noninvasive prenatal testing will be available to Aetna's members as an in-network benefit, starting Feb. 15. 

The decision by Aetna follows a review of NxGen's products' features, such as full-gene sequencing. The health plan is the third-largest in the US with more than 46 million members. It will cover NxGen MDx's testing at a national level. 

NxGen MDx offers testing for up to 120 various genetic disorders. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.